tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market
Advertisement

Sonnet BioTherapeutics Holdings (SONN) Revenue

Compare
610 Followers

Sonnet BioTherapeutics Holdings Revenue

Sonnet BioTherapeutics Holdings had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 1.00M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Sonnet BioTherapeutics Holdings had annual revenue of 18.63K with -87.40% growth.
Revenue (ttm)
1.00M
Revenue Growth
1689.52%
P/S Ratio
1283.71
Revenue/Employee
$1,433
Employees
13
Market Cap
$23.91M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.63K-129.18K-87.40%
Dec 31, 2023
147.81K-202.14K-57.76%
Dec 31, 2022
349.94K-133.68K-27.64%
Dec 31, 2021
483.63K+∞%
Dec 31, 2020
0.00-40.61M-100.00%
Dec 31, 2019
40.61M9.88M+32.15%
Dec 31, 2018
30.73M-10.70M-25.82%
Dec 31, 2017
41.43M-269.14K-0.65%
Dec 31, 2016
41.70M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis